vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and GREENE COUNTY BANCORP INC (GCBC). Click either name above to swap in a different company.

GREENE COUNTY BANCORP INC is the larger business by last-quarter revenue ($22.2M vs $19.2M, roughly 1.2× Apyx Medical Corp). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -6.8%, a 53.1% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 23.8%). GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 18.9%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.

APYX vs GCBC — Head-to-Head

Bigger by revenue
GCBC
GCBC
1.2× larger
GCBC
$22.2M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+10.9% gap
APYX
34.7%
23.8%
GCBC
Higher net margin
GCBC
GCBC
53.1% more per $
GCBC
46.3%
-6.8%
APYX
More free cash flow
GCBC
GCBC
$9.0M more FCF
GCBC
$6.2M
$-2.8M
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
18.9%
GCBC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
APYX
APYX
GCBC
GCBC
Revenue
$19.2M
$22.2M
Net Profit
$-1.3M
$10.3M
Gross Margin
62.6%
Operating Margin
0.1%
52.0%
Net Margin
-6.8%
46.3%
Revenue YoY
34.7%
23.8%
Net Profit YoY
71.9%
37.4%
EPS (diluted)
$0.60

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
GCBC
GCBC
Q4 25
$19.2M
$22.2M
Q3 25
$12.9M
$21.5M
Q2 25
$11.4M
$20.5M
Q1 25
$9.4M
$20.1M
Q4 24
$14.2M
$17.9M
Q3 24
$11.5M
$16.9M
Q2 24
$12.1M
$16.6M
Q1 24
$10.2M
$15.7M
Net Profit
APYX
APYX
GCBC
GCBC
Q4 25
$-1.3M
$10.3M
Q3 25
$-2.0M
$8.9M
Q2 25
$-3.8M
$9.3M
Q1 25
$-4.2M
$8.1M
Q4 24
$-4.6M
$7.5M
Q3 24
$-4.7M
$6.3M
Q2 24
$-6.6M
$6.7M
Q1 24
$-7.6M
$5.9M
Gross Margin
APYX
APYX
GCBC
GCBC
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
GCBC
GCBC
Q4 25
0.1%
52.0%
Q3 25
-6.5%
47.4%
Q2 25
-22.6%
53.5%
Q1 25
-32.4%
44.6%
Q4 24
-21.4%
45.0%
Q3 24
-31.6%
39.6%
Q2 24
-45.7%
41.2%
Q1 24
-64.6%
39.4%
Net Margin
APYX
APYX
GCBC
GCBC
Q4 25
-6.8%
46.3%
Q3 25
-15.4%
41.2%
Q2 25
-33.2%
45.6%
Q1 25
-44.0%
40.1%
Q4 24
-32.5%
41.7%
Q3 24
-40.9%
37.1%
Q2 24
-54.0%
40.6%
Q1 24
-74.0%
37.3%
EPS (diluted)
APYX
APYX
GCBC
GCBC
Q4 25
$0.60
Q3 25
$0.52
Q2 25
$0.55
Q1 25
$0.47
Q4 24
$0.44
Q3 24
$0.37
Q2 24
$-0.19
$0.39
Q1 24
$-0.22
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
GCBC
GCBC
Cash + ST InvestmentsLiquidity on hand
$31.7M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$258.3M
Total Assets
$66.8M
$3.1B
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
GCBC
GCBC
Q4 25
$31.7M
Q3 25
$25.1M
Q2 25
$29.3M
Q1 25
$31.0M
$155.5M
Q4 24
$31.7M
$166.4M
Q3 24
$28.0M
Q2 24
$32.7M
$190.4M
Q1 24
$37.3M
Total Debt
APYX
APYX
GCBC
GCBC
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
GCBC
GCBC
Q4 25
$14.5M
$258.3M
Q3 25
$5.8M
$248.2M
Q2 25
$7.3M
$238.8M
Q1 25
$10.5M
$229.0M
Q4 24
$14.2M
$218.4M
Q3 24
$11.0M
$216.3M
Q2 24
$14.7M
$206.0M
Q1 24
$20.3M
$199.2M
Total Assets
APYX
APYX
GCBC
GCBC
Q4 25
$66.8M
$3.1B
Q3 25
$57.4M
$3.1B
Q2 25
$58.2M
$3.0B
Q1 25
$60.2M
$3.0B
Q4 24
$64.8M
$3.0B
Q3 24
$60.7M
$2.9B
Q2 24
$65.4M
$2.8B
Q1 24
$70.7M
$2.9B
Debt / Equity
APYX
APYX
GCBC
GCBC
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
GCBC
GCBC
Operating Cash FlowLast quarter
$-2.5M
$6.4M
Free Cash FlowOCF − Capex
$-2.8M
$6.2M
FCF MarginFCF / Revenue
-14.6%
28.0%
Capex IntensityCapex / Revenue
1.4%
0.9%
Cash ConversionOCF / Net Profit
0.62×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$47.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
GCBC
GCBC
Q4 25
$-2.5M
$6.4M
Q3 25
$-3.5M
$7.0M
Q2 25
$-1.2M
$28.0M
Q1 25
$-702.0K
$7.3M
Q4 24
$-2.9M
$5.3M
Q3 24
$-4.4M
$2.1M
Q2 24
$-4.3M
$24.9M
Q1 24
$-6.3M
$5.6M
Free Cash Flow
APYX
APYX
GCBC
GCBC
Q4 25
$-2.8M
$6.2M
Q3 25
$-4.1M
$6.5M
Q2 25
$-1.5M
$27.3M
Q1 25
$-757.0K
$7.3M
Q4 24
$-3.2M
$5.1M
Q3 24
$-4.6M
$2.0M
Q2 24
$-4.6M
$23.4M
Q1 24
$-6.4M
$4.9M
FCF Margin
APYX
APYX
GCBC
GCBC
Q4 25
-14.6%
28.0%
Q3 25
-31.5%
30.4%
Q2 25
-13.2%
133.3%
Q1 25
-8.0%
36.1%
Q4 24
-22.4%
28.6%
Q3 24
-40.0%
11.8%
Q2 24
-38.0%
141.2%
Q1 24
-62.2%
31.3%
Capex Intensity
APYX
APYX
GCBC
GCBC
Q4 25
1.4%
0.9%
Q3 25
4.0%
1.9%
Q2 25
2.3%
3.4%
Q1 25
0.6%
0.3%
Q4 24
1.7%
1.0%
Q3 24
1.3%
0.9%
Q2 24
2.4%
9.1%
Q1 24
0.3%
4.2%
Cash Conversion
APYX
APYX
GCBC
GCBC
Q4 25
0.62×
Q3 25
0.78×
Q2 25
3.00×
Q1 25
0.91×
Q4 24
0.71×
Q3 24
0.34×
Q2 24
3.70×
Q1 24
0.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons